Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma

被引：0
|
作者：
Song, Huangqin [1 ,2 ,3 ,4 ]
Zhao, Haichao [1 ,2 ,3 ,4 ]
Chen, Changzhou [3 ,4 ]
Zhang, Donglin [1 ,2 ,3 ,4 ]
Wang, Xiaoxiao [1 ,2 ,3 ,4 ]
He, Jiefeng [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[3] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai, Peoples R China
[4] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[6] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3, Taiyuan 030032, Peoples R China
来源：
MEDICINE | 2023年 / 102卷 / 07期
关键词：
hepatocellular carcinoma; immune infiltrates analyses; STIL; T-CELLS; CANCER;
D O I：
10.1097/MD.0000000000033004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Overexpression of SCL/TAL1 interrupting locus (STIL) has been observed in various cancer types. However, the clinical significance of STIL in hepatocellular carcinoma (HCC) remains unknown. Cox regression and Kaplan-Meier survival analyses were performed to evaluate the prognostic value of STIL. Go and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses were also carried out. Immune infiltrates analyses were conducted based on TIMER (Tumor Immune Estimation Resource) and GAPIA databases. STIL expression was highly expressed in HCC tissues, based on multiple databases. KEGG and GO enrichment analysis showed STIL-related to tumorigenesis and progress. Furthermore, STIL was significantly correlated with immune infiltration. STIL serves as a biomarker for the prediction of patient survival.
引用
收藏
页数：8
相关论文
共 50 条
  • [1] Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
    Yan, Xiaotong
    Yao, Mingjie
    Wen, Xiajie
    Zhu, Yiwei
    Zhao, Erjiang
    Qian, Xiangjun
    Chen, Xiangmei
    Lu, Weiquan
    Lv, Quanjun
    Zhang, Ling
    Lu, Fengmin
    [J]. ONCOTARGETS AND THERAPY, 2019, 12 : 1957 - 1964
  • [2] Elevated platelet distribution width predicts poor prognosis in hepatocellular carcinoma
    Zuo, Xiaomin
    Kong, Weihao
    Feng, Linfei
    Zhang, Huabing
    Meng, Xiangling
    Chen, Wei
    [J]. CANCER BIOMARKERS, 2019, 24 (03) : 307 - 313
  • [3] Ube2s expression is elevated in hepatocellular carcinoma and predicts poor prognosis of the patients
    Li, Qi
    Zhao, Yang
    Shi, Xiuying
    Fan, Chuifeng
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (02): : 781 - 787
  • [4] Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma
    Dai, Tianxing
    Peng, Lingrong
    Lin, Guozhen
    Li, Yang
    Yao, Jia
    Deng, Yinan
    Li, Hua
    Wang, Genshu
    Liu, Wei
    Yang, Yang
    Chen, Guihua
    Wang, Guoying
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (06) : 1049 - 1063
  • [5] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    [J]. Medical Oncology, 2013, 30
  • [6] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    He, Lu
    Zhou, Xinke
    Qu, Chen
    Tang, Yunqiang
    Zhang, Qiong
    Hong, Jian
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [7] High Expression of POGK Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Xu, Wenxiong
    Huang, Yanlin
    Mei, Yongyu
    Zhang, Yeqiong
    Luo, Qiumin
    Zhu, Shu
    Peng, Liang
    Gao, Zhiliang
    Liu, Ying
    Li, Jianguo
    [J]. CURRENT ONCOLOGY, 2022, 29 (11) : 8650 - 8667
  • [8] Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
    Jiang, Jie
    Liu, Bin
    Liu, Ruilin
    Yang, Wenzhuo
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2517 - 2537
  • [9] Elevated NDC1 expression predicts poor prognosis and correlates with immunity in hepatocellular carcinoma
    Liu, Qingqing
    Gu, Liugen
    Qiu, Jianwei
    Qian, Junbo
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (01) : 245 - 264
  • [10] FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma
    Wang, Yan
    Sun, Mengjing
    Liu, Jibin
    Liu, Ying
    Jiang, Chunyi
    Zhu, Huijun
    Wang, Wei
    Wang, Yao
    [J]. ONCOLOGY LETTERS, 2020, 19 (01) : 795 - 804
12345